{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:43:28Z","timestamp":1790862208418,"version":"4.1.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jaci.2018.03.021","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:22:00Z","timestamp":1527168120000},"page":"604-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature"],"prefix":"10.1016","volume":"143","author":[{"given":"Kunal","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thy Nhat","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Doytcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Renert-Yuval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Czarnowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Magidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeriel D.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Chi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.03.021_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2010.12.019","article-title":"Keratin gene mutations in disorders of human skin and its appendages","volume":"508","author":"Chamcheu","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jaci.2018.03.021_bib2","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8584.1","article-title":"Recent advances in understanding ichthyosis pathogenesis","volume":"5","author":"Marukian","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.jaci.2018.03.021_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00128071-200304020-00002","article-title":"Ichthyosis: etiology, diagnosis, and management","volume":"4","author":"DiGiovanna","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2009.11.020","article-title":"Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Soreze 2009","volume":"63","author":"Oji","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1194\/jlr.R800002-JLR200","article-title":"Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism","volume":"49","author":"Elias","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jaci.2018.03.021_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1529-8019.2012.01517.x","article-title":"Complications of ichthyosis beyond the skin","volume":"26","author":"Diaz","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2018.03.021_bib7","first-page":"61","article-title":"Health-related quality of life among patients with ichthyosis","volume":"14","author":"Ganemo","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1525-1470.2010.01160.x","article-title":"Annual direct and indirect health costs of the congenital ichthyoses","volume":"27","author":"Styperek","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2133.2011.10701.x","article-title":"Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study in adults using focus groups","volume":"166","author":"Mazereeuw-Hautier","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.0309-2402.2003.02820.x","article-title":"Quality of life in adults with congenital ichthyosis","volume":"44","author":"Ganemo","year":"2003","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.jaci.2018.03.021_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/11311070-000000000-00000","article-title":"Ichthyosis: clinical manifestations and practical treatment options","volume":"10","author":"Oji","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2018.03.021_bib12","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1067\/mjd.2001.113721","article-title":"Isotretinoin effects on bone","volume":"45","author":"DiGiovanna","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1529-8019.2012.01527.x","article-title":"Systemic retinoids in the management of ichthyoses and related skin types","volume":"26","author":"Digiovanna","year":"2013","journal-title":"Dermatol Ther"},{"issue":"suppl","key":"10.1016\/j.jaci.2018.03.021_bib14","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0190-9622(08)80256-3","article-title":"Side effects of systemic retinoids and their clinical management","volume":"27","author":"Saurat","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2340\/00015555-0415","article-title":"Congenital ichthyosis: an overview of current and emerging therapies","volume":"88","author":"Vahlquist","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2018.03.021_bib16","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1172\/JCI24834","article-title":"Mutations in lipid transporter ABCA12 in harlequin ichthyosis and\u00a0functional recovery by corrective gene transfer","volume":"115","author":"Akiyama","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.03.021_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/nm1196-1263","article-title":"Corrective gene transfer in the human skin disorder lamellar ichthyosis","volume":"2","author":"Choate","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib18","first-page":"349","article-title":"Ichthyoses: differential diagnosis and molecular genetics","volume":"16","author":"Oji","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng1493","article-title":"Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity","volume":"37","author":"Descargues","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.03.021_bib20","doi-asserted-by":"crossref","first-page":"e1005389","DOI":"10.1371\/journal.pgen.1005389","article-title":"KLK5 inactivation reverses cutaneous hallmarks of Netherton syndrome","volume":"11","author":"Furio","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaci.2018.03.021_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jid.2016.09.034","article-title":"Alterations in epidermal eicosanoid metabolism contribute to inflammation and impaired late differentiation in FLG-mutated atopic dermatitis","volume":"137","author":"Blunder","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib22","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1038\/ncomms14609","article-title":"PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis","volume":"8","author":"Hirabayashi","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2018.03.021_bib23","doi-asserted-by":"crossref","first-page":"e0170708","DOI":"10.1371\/journal.pone.0170708","article-title":"A defect in NIPAL4 is associated with autosomal recessive congenital ichthyosis in American bulldogs","volume":"12","author":"Casal","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.03.021_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/exd.13000","article-title":"Functional study of TGM1 missense mutations in autosomal recessive congenital ichthyosis","volume":"25","author":"Numata","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib25","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/hmg\/ddq145","article-title":"Interleukin-1 alpha blockade prevents hyperkeratosis in an in\u00a0vitro model of lamellar ichthyosis","volume":"19","author":"O'Shaughnessy","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2018.03.021_bib26","doi-asserted-by":"crossref","first-page":"e1006651","DOI":"10.1371\/journal.pgen.1006651","article-title":"A de novo variant in the ASPRV1 gene in a dog with ichthyosis","volume":"13","author":"Bauer","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaci.2018.03.021_bib27","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/sj.jid.5700284","article-title":"Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome","volume":"126","author":"Descargues","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jid.2016.11.012","article-title":"Gene-targeted next generation sequencing identifies PNPLA1 mutations in patients with a phenotypic spectrum of autosomal recessive congenital ichthyosis: the impact of consanguinity","volume":"137","author":"Vahidnezhad","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/bjd.14807","article-title":"Predictive phenotyping of inherited ichthyosis by next-generation DNA sequencing","volume":"176","author":"Saito","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2340\/00015555-2418","article-title":"Spectrum of autosomal recessive congenital ichthyosis in Scandinavia: clinical characteristics and novel and recurrent mutations in 132 patients","volume":"96","author":"Pigg","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2018.03.021_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/ijd.12950","article-title":"Novel mutations in the genes TGM1 and ALOXE3 underlying autosomal recessive congenital ichthyosis","volume":"55","author":"Ullah","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib32","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/bjd.15315","article-title":"Deficient stratum corneum intercellular lipid in a Japanese patient with lamellar ichthyosis by a homozygous deletion mutation in SDR9C7","volume":"177","author":"Takeichi","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2340\/00015555-2550","article-title":"Japanese case of ichthyosiform erythroderma with a novel mutation in NIPAL4\/ichthyin","volume":"97","author":"Kusakabe","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2018.03.021_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1743","article-title":"Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris","volume":"38","author":"Smith","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.03.021_bib35","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/jid.2012.160","article-title":"The expression of epidermal lipoxygenases and transglutaminase-1 is perturbed by NIPAL4 mutations: indications of a common metabolic pathway essential for skin barrier homeostasis","volume":"132","author":"Li","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2230.2005.01818.x","article-title":"Structural, enzymatic and molecular studies in a series of nonbullous congenital ichthyosiform erythroderma patients","volume":"30","author":"Kawashima","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib37","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2353\/ajpath.2009.080860","article-title":"Premature terminal differentiation and a reduction in specific proteases associated with loss of ABCA12 in Harlequin ichthyosis","volume":"174","author":"Thomas","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2018.03.021_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2133.1994.tb08578.x","article-title":"Filaggrin expression in epidermolytic ichthyosis (epidermolytic hyperkeratosis)","volume":"131","author":"Ishida-Yamamoto","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/1523-1747.ep12873301","article-title":"Heterogeneity in harlequin ichthyosis, an inborn error of epidermal keratinization: variable morphology and structural protein expression and a defect in lamellar granules","volume":"94","author":"Dale","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0190-9622(98)70575-4","article-title":"Transglutaminase 1 expression in a patient with features of harlequin ichthyosis: case report","volume":"38","author":"Choate","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cyto.2014.11.023","article-title":"New pathogenic and therapeutic paradigms in atopic dermatitis","volume":"73","author":"Malajian","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2018.03.021_bib42","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/sj.jid.5701205","article-title":"Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan","volume":"128","author":"Nomura","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib43","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/bmj.1.5493.947","article-title":"Clinical features of autosomal dominant and sex-linked ichthyosis in an English population","volume":"1","author":"Wells","year":"1966","journal-title":"Br Med J"},{"key":"10.1016\/j.jaci.2018.03.021_bib44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/08923973.2015.1115518","article-title":"A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels","volume":"38","author":"Yalcin","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jaci.2018.03.021_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jamadermatol.2015.5827","article-title":"Intrafamily and interfamilial phenotype variation and immature immunity in patients with Netherton syndrome and Finnish SPINK5 founder mutation","volume":"152","author":"Hannula-Jouppi","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib46","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib47","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/jid.2010.233","article-title":"Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model","volume":"130","author":"Briot","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib48","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/1346-8138.12209","article-title":"Case of Netherton syndrome with an elevated serum thymus and activation-regulated chemokine level","volume":"40","author":"Akagi","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib49","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/jid.2011.124","article-title":"Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin","volume":"131","author":"Fontao","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2222.2004.01860.x","article-title":"Association between polymorphisms in serine protease inhibitor, kazal type 5 and asthma phenotypes in a large German population sample","volume":"34","author":"Kabesch","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.03.021_bib51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.2003.05243.x","article-title":"Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population","volume":"148","author":"Kato","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng728","article-title":"Gene polymorphism in Netherton and common atopic disease","volume":"29","author":"Walley","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.03.021_bib53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2016.07.019","article-title":"An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis","volume":"139","author":"Paller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib54","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib56","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jid.2016.04.032","article-title":"The spectrum of mild to severe psoriasis vulgaris is defined by a common activation of IL-17 pathway genes, but with key differences in immune regulatory genes","volume":"136","author":"Kim","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000051607","article-title":"Clinico-immunological heterogeneity in Comel-Netherton syndrome","volume":"202","author":"Van Gysel","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2018.03.021_bib58","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib59","first-page":"744","article-title":"Caspase-1 activity of stratum corneum and serum interleukin-18 level are increased in patients with Netherton syndrome","volume":"159","author":"Hosomi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib60","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1084\/jem.20131797","article-title":"Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome","volume":"211","author":"Furio","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib61","doi-asserted-by":"crossref","first-page":"e0159673","DOI":"10.1371\/journal.pone.0159673","article-title":"Activation of molecular signatures for antimicrobial and innate defense responses in skin with transglutaminase 1 deficiency","volume":"11","author":"Haneda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.03.021_bib62","first-page":"5269","article-title":"Keratin 1 maintains skin integrity and participates in an inflammatory network in skin through interleukin-18","volume":"125","author":"Roth","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jaci.2018.03.021_bib63","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2014.03.003","article-title":"Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology","volume":"133","author":"Khattri","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib64","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaci.2014.10.037","article-title":"Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection","volume":"135","author":"Esaki","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib65","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12920-015-0133-x","article-title":"Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways","volume":"8","author":"Ewald","year":"2015","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jaci.2018.03.021_bib66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jid.2016.09.037","article-title":"An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease","volume":"137","author":"Ungar","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response","volume":"134","author":"Dhingra","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib68","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","article-title":"Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis","volume":"124","author":"Guttman-Yassky","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib69","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jaci.2015.08.013","article-title":"Petrolatum: Barrier repair and antimicrobial responses underlying this \u201cinert\u201d moisturizer","volume":"137","author":"Czarnowicki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.jaci.2018.03.021_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2018.03.021_bib72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13073-016-0384-y","article-title":"XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits","volume":"8","author":"Fang","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib73","doi-asserted-by":"crossref","first-page":"12846","DOI":"10.1038\/ncomms12846","article-title":"Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd","volume":"7","author":"Wang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2018.03.021_bib74","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","article-title":"Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin","volume":"138","author":"Esaki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib75","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"Suarez-Farinas","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib76","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/exd.13378","article-title":"Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active psoriasis and localized with keratinocytes, dendritic cells and other leukocytes","volume":"26","author":"Fuentes-Duculan","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib77","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib78","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/cea.13040","article-title":"Dust mite induces multiple polar T cell axes in human skin","volume":"47","author":"Malik","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.03.021_bib79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/nyas.13280","article-title":"The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases","volume":"1417","author":"Walsh","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2018.03.021_bib80","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk","volume":"122","author":"Tortola","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.03.021_bib81","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-regulation of Th17 cytokines and the IL-36 cytokines in\u00a0vitro and in\u00a0vivo: implications in psoriasis pathogenesis","volume":"131","author":"Carrier","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib82","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/MIB.0000000000000811","article-title":"Profiles of lamina propria T helper cell subsets discriminate between ulcerative colitis and Crohn's disease","volume":"22","author":"Li","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2018.03.021_bib83","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaci.2014.07.061","article-title":"Peeling off the genetics of atopic dermatitis-like congenital disorders","volume":"134","author":"Samuelov","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib84","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng2020","article-title":"Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema","volume":"39","author":"Sandilands","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.03.021_bib85","first-page":"137","article-title":"The epidemiology of atopic dermatitis at a tertiary referral skin center in Singapore","volume":"17","author":"Tay","year":"1999","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib86","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaci.2014.07.008","article-title":"IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome","volume":"134","author":"Hannula-Jouppi","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib87","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaad.2017.10.026","article-title":"The spectrum of manifestations in DSP (desmoplakin) SR6 domain mutations: immunophenotyping and response to ustekinumab","volume":"78","author":"Paller","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib88","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/bjd.14969","article-title":"Transcriptomic analysis of skin in a case of ichthyosis Curth-Macklin caused by a KRT1 mutation","volume":"175","author":"Ortega-Recalde","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib89","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","volume":"124","author":"Zaba","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib91","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jaci.2015.09.055","article-title":"The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases","volume":"137","author":"Harden","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib92","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/jid.2009.67","article-title":"Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines","volume":"129","author":"Jansen","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib93","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2133.2009.09547.x","article-title":"Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis","volume":"162","author":"Kamsteeg","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib94","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cyto.2016.05.012","article-title":"Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines","volume":"84","author":"Dietrich","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2018.03.021_bib95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis","volume":"140","author":"Johnston","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2514","article-title":"An\u00a0analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target","volume":"9","author":"Mahil","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib97","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/jid.2014.532","article-title":"IL-36gamma (IL-1F9) is a biomarker for psoriasis skin lesions","volume":"135","author":"D'Erme","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib98","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.det.2017.02.006","article-title":"An update on the pathophysiology of atopic dermatitis","volume":"35","author":"Malik","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2018.03.021_bib99","doi-asserted-by":"crossref","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","article-title":"TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma","volume":"7","author":"Choy","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4049\/jimmunol.1102216","article-title":"IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner","volume":"188","author":"Newcomb","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib101","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaci.2010.11.043","article-title":"Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production","volume":"127","author":"Newcomb","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib102","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2340\/00015555-2510","article-title":"Whole-exome-sequencing reveals small deletions in CASP14 in patients with autosomal recessive inherited ichthyosis","volume":"97","author":"Kirchmeier","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2018.03.021_bib103","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.0901860","article-title":"IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation","volume":"184","author":"Sehra","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib104","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.immuni.2006.02.006","article-title":"Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus","volume":"24","author":"Howell","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.03.021_bib105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib106","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","article-title":"Tight junction defects in patients with atopic dermatitis","volume":"127","author":"De Benedetto","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib107","doi-asserted-by":"crossref","first-page":"e0161759","DOI":"10.1371\/journal.pone.0161759","article-title":"Impaired tight junctions in atopic dermatitis skin and in a skin-equivalent model treated with interleukin-17","volume":"11","author":"Yuki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.03.021_bib108","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2353\/ajpath.2010.090597","article-title":"Transglutaminase1 preferred substrate peptide K5 is an efficient tool in diagnosis of lamellar ichthyosis","volume":"176","author":"Akiyama","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2018.03.021_bib109","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/ced.12456","article-title":"Identification and clinical consequences of a novel mutation in the gene for transglutaminase 1 in a patient with lamellar ichthyosis","volume":"40","author":"Pietrusinski","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib110","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1073\/pnas.96.15.8402","article-title":"A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation","volume":"96","author":"Nemes","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.03.021_bib111","doi-asserted-by":"crossref","first-page":"11013","DOI":"10.1074\/jbc.274.16.11013","article-title":"Involucrin cross-linking by transglutaminase 1. Binding to membranes directs residue specificity","volume":"274","author":"Nemes","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2018.03.021_bib112","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/jid.2013.199","article-title":"Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model","volume":"133","author":"Nakajima","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib113","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.imlet.2017.02.004","article-title":"IL-17 axis accelerates the inflammatory progression of obese in mice via TBK1 and IKBKE pathway","volume":"184","author":"Lee","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2018.03.021_bib114","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.4049\/jimmunol.1001269","article-title":"IL-17 regulates adipogenesis, glucose homeostasis, and obesity","volume":"185","author":"Zuniga","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/exd.13336","article-title":"Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment","volume":"27","author":"Guttman-Yassky","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib116","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1586\/1744666X.2015.1095092","article-title":"Secukinumab (AIN457) for the treatment of psoriasis","volume":"11","author":"Lopez-Ferrer","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib117","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2015.01.018","article-title":"Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial","volume":"136","author":"Krueger","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib118","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of Psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2018.03.021_bib119","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","article-title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials","volume":"386","author":"Griffiths","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2018.03.021_bib120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis\u2014results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.03.021_bib121","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14728222.2014.889686","article-title":"Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?","volume":"18","author":"Chiricozzi","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jaci.2018.03.021_bib122","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings","volume":"133","author":"Martin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib123","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib124","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/13543784.2013.806483","article-title":"IL-17 targeted therapies for psoriasis","volume":"22","author":"Chiricozzi","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2018.03.021_bib125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib126","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.autrev.2016.09.004","article-title":"Psoriasis and autoimmunity","volume":"15","author":"Sticherling","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2018.03.021_bib127","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2014.01.025","article-title":"Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis","volume":"133","author":"Sofen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","article-title":"Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \u201ctype 1\u201d inflammatory gene expression","volume":"25","author":"Lew","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2018.03.021_bib129","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2018.03.021_bib130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/jid.2011.304","article-title":"A phase III, randomized, controlled trial of the fully human IL-12\/23 mAb briakinumab in moderate-to-severe psoriasis","volume":"132","author":"Gordon","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.021_bib131","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918307590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918307590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:15:33Z","timestamp":1758791733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918307590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0091674918307590"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.03.021","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}